Hugendubel.info - Die B2B Online-Buchhandlung 

Merkliste
Die Merkliste ist leer.
Bitte warten - die Druckansicht der Seite wird vorbereitet.
Der Druckdialog öffnet sich, sobald die Seite vollständig geladen wurde.
Sollte die Druckvorschau unvollständig sein, bitte schliessen und "Erneut drucken" wählen.

Liver Fluke, Opisthorchis viverrini Related Cholangiocarcinoma

Liver Fluke Related Cholangiocarcinoma
BuchGebunden
367 Seiten
Englisch
Springererschienen am04.09.20232023
This volume discusses new developments in the etiology, diagnosis, and treatment of cholangiocarcinoma induced by the liver fluke Opisthorchis viverrini.mehr
Verfügbare Formate
BuchGebunden
EUR139,09
TaschenbuchKartoniert, Paperback
EUR106,99
E-BookPDF1 - PDF WatermarkE-Book
EUR128,39

Produkt

KlappentextThis volume discusses new developments in the etiology, diagnosis, and treatment of cholangiocarcinoma induced by the liver fluke Opisthorchis viverrini.
Details
ISBN/GTIN978-3-031-35165-5
ProduktartBuch
EinbandartGebunden
Verlag
Erscheinungsjahr2023
Erscheinungsdatum04.09.2023
Auflage2023
ReiheRecent Results in Cancer Research
Seiten367 Seiten
SpracheEnglisch
IllustrationenXII, 367 p. 166 illus., 110 illus. in color.
Artikel-Nr.53431711
Rubriken
GenreMedizin

Inhalt/Kritik

Inhaltsverzeichnis
Introduction.- Liver flukes and cancer: epidemiology including other risk factors.- Carcinogenesis/Biochemistry.- Genetics.- Diagnosis.- New imaging techniques.- Pathology.- Surgery/Clinical.- Other treatment.- Palliative care.- Control options.- Digital innovations.mehr

Schlagworte

Autor

Assoc. Prof. Narong Khuntikeo is the director and initiator of the Cholangiocarcinoma (CCA) Research Institute (CARI) and The Cholangiocarcinoma Screening and Care Program (CASCAP) at Khon Kaen University, Thailand. The institute and program aim to reduce the mortality caused by CCA by reducing the incidence of infection with the liver fluke Opisthorchis viverrini, the main risk factor for developing CCA, as well as developing new clinical approaches to early disease diagnosis, surgery and chemotherapy. To date over 600,000 at-risk individuals have been screened ba CASCAP to detect early stage disease.Prof. Khuntikeo received his MD at the Faculty of Medicine in Khon Kaen in 1984 and received a fellowship in Hepato-Pancreatic Biliary Surgery and Liver Transplantation at the Princess Alexandra Hospital, Brisbane in 1994. He is the recipient of numerous awards and extensive funding for his work on combatting CCA.
Ross H Andrews and Trevor N Petney have done extensive work on O. viverrini including its systematics, genetic variability, host choice and transmission dynamics. Both are senior advisors at the Cholangiocarcinoma Research Institute, Khon Kaen University. Shahid A Khan is an internationally renowned liver specialist in biliary cancer.
Weitere Artikel von
Herausgegeben:Khuntikeo, Narong
Weitere Artikel von
Andrews, Ross H.